Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2007-07-26
2010-06-29
Haq, Shafiqul (Department: 1641)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S007920, C435S007930, C435S007950, C435S069300, C436S506000, C436S513000, C436S518000, C530S387900
Reexamination Certificate
active
07745146
ABSTRACT:
The present invention is in the field of autoimmunity. More specifically, the present invention relates to the detection of autoantibodies to domain 4 of beta 2-glycoprotein I (β2-GPI) as an indicator for atherosclerosis.
REFERENCES:
patent: 4981785 (1991-01-01), Nayak
patent: 5358691 (1994-10-01), Clark et al.
patent: 5885530 (1999-03-01), Babson et al.
patent: 6159750 (2000-12-01), Edmonds
patent: 6585210 (2003-07-01), Lee
Veres et al., 2004. Antiphospholipid antibodies in acute coronary syndrome. Lupus 13: 423-427.
Lopez et al., 2004. Anti-beta2-glycoprotein I and antiphosphatidylserine antibodies are predictors of arterial thrombosis in patients with antiphospholipid syndrome. American Journal Clinical Pathology 121: 142-149.
Blank M, et al., Prevention of experimental antiphospholipid syndrome and endothelial cell activation by synthetic peptides, 1999,PNAS96:5164-8.
Hunt J., et al., Identification of a region of beta 2-glycoprotein I critical for lipid binding and anti-cardiolipin antibody cofactor activity, 1993,PNAS90:2141-5.
Igarashi M., et al, Human beta2-glycoprotein I as an anticardiolipin cofactor determined using mutants expressed by a baculovirus system, 1996,Blood, 87 (8): 3262-70.
Iverson GM, et al., Anti-B2 glycoprotein I (B2GPI) autoantibodies recognize an epitope on the first domain of B2GPI, 1998,PNAS95:15542-15546.
Iverson GM, et al., The orientation of beta2GPI on the plate is important for the binding of anti-beta2GPI autoantibodies by ELISA, 2002,J. of Autoimmunity, 18: 289-297.
Iverson GM, et al., Use of single point mutations in domain I of beta 2-glycoprotein I to determine fine antigenic specificity of antiphospholipid, J. Immunol. 169: 7097-7103, 2002.
Iverson GM et al, Patients with atherosclerotic syndrome, negative in anti-cardiolipin assays, make IgA autoantibodies that preferentially target domain 4 or, J. Autoimmunity 27: 266-271, 2006.
George J, et al, Target recognition of beta2-glycoprotein I (beta2GPI)-dependent anticardiolipin antibodies: evidence for involvement of the fourth domain of beta2GPI in antibody binding, 1998,J Immunol.160(8):3917-3923.
Greco TP, et al., Testing for the antiphospholipid syndrome: importance of IgA anti-beta 2-glycoprotein I, 2000,Lupus, 9:33-41.
Kahles T, et al., Phosphatidylserine IgG and beta-2-glycoprotein I IgA antibodies may be a risk factor for ischaemic stroke, 2005,Rheumatology44(9):1161-5.
Kasahara H, et al., Antigenic structures recognized by anti-beta2-glycoprotein I auto-antibodies, 2005, Int. Immuno.I 17:1533-42.
Koike T, et al., Beta 2-glycoprotein I-anti-beta 2-glycoprotein I interaction, 2000, J. Autoimmun 15: 97-100.
Lozier J. et al., Complete amino acid sequence of human plasma beta 2-glycoprotein I, 1984, PNAS 81:3640-4.
McNeeley PA, et al., Beta2-glycoprotein I-dependent anticardiolipin antibodies preferentially bind the amino terminal domain of beta2-glycoprotein I, 2001, Thromb Haemost 86:590-5.
Ranzolin A, et al., Anti-beta2-glycoprotein I antibodies as risk factors for acute myocardial infarction, 2004 Arg Bras Cardiol. 83(2):141-4; 137-40.
Staub HL, et al., Antibodies to the atherosclerotic plaque components beta2-glycoprotein I and heat-shock proteins as risk factors for acute cerebral ischemia, 2003, Arq. Neuropsiquiat 61(3B):757-63.
Yang CD, et al., The fifth domain of B2-glycoprotein I contains antigenic epitopes recognized by anticardiolipin antibodies derived from patients with the antiphospholipid syndrome, 1997, APLAR J Rheumatol 1:96-100.
Takatsu et al., “Acute myocardial infarction associated with systemic lupus erythematosus documented by coronary arteriograms.” Chest, 1985:88:147-149.
Takeuchi et al., “Primary antiphospholipid syndrome with acute myocardial infarction recanalised by PTCA.” Heart, 1998:79:96-98.
Binder Walter L.
Iverson G. Michael
Norman Gary L.
Axford Laurie A.
Grun James L
Haq Shafiqul
INOVA Diagnostics, Inc.
The Nath Law Group
LandOfFree
Compositions and methods for diagnosing patients with acute... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and methods for diagnosing patients with acute..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for diagnosing patients with acute... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4175727